Past event: Pre-Filled Syringes and Injectable Drug Devices Conference

The Future of Drug Delivery & Combination Product Device Design

NEW FOR 2023:
  • Pre-Conference Focus Day: Advances in PFS Design for Enhanced Delivery
Main Conference Afternoon Streams
  • DAY 1: A) Novel Drug Products and Large Volume Delivery B) Sustainability for Injectable Delivery Devices
  • DAY 2: A) Primary Packaging Development B) Connected Delivery Devices
The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to increase patient centricity, aid self-administration and deliver biologics that have large-volumes and novel formulations. This year’s conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation.

This 15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference will be bigger than ever, with a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference comprising of morning keynote plenaries and parallel afternoon topic streams as detailed below
  • Novel Drug Products and Large Volume Delivery
  • Sustainability for Injectable Delivery Devices
  • Primary Packaging Development
  • Connected Drug Delivery Devices
With the injectable drug delivery industry growing exponentially year-to-year, administration using pre-filled syringes, auto-injectors, and pen-injectors are increasingly common. Innovations in device technology, such as smart devices are leading the way in device design in addition to injectable delivery devices for novel and long-acting therapeutics. We are starting to see environmental sustainability being incorporated into aspects of device manufacturing, design and the use of the device. This year’s conference looks to address the hot topics of the injectable drug delivery industry through case studies and industry insights.

This event will not only bring you key insights you need to expand and enhance your injectable device portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in January 2023.

Benefits of Attending

  • Engage with industry representatives on the latest trends within the pre-filled syringe and injectable device market
  • Hear about new technological advances in the delivery of large volume drugs
  • Explore updates to drug device combination product design approaches considering patient preference at the forefront with case studies from big pharma representatives
  • Understand the latest regulatory requirements from regulatory experts surrounding medical devices and digital health
  • Delve into the considerations for material components for the development of primary packaging
  • Gain insight into how big pharma are incorporating sustainable approaches into drug device design

Who should attend

Directors, Heads of Departments and Managers for the following areas:
  • Device Development
  • Device Engineering
  • Combination Product Development
  • Drug Delivery Devices
  • Primary Packaging Development
  • Digital Health
  • Sustainability and Circular Economy
  • Large Volume Drug Delivery
  • Novel Drug Product Formulation
  • Regulatory Affairs


  • Aaron Gowson, Public Affairs Manager, Chiesi Ltd
  • Abha Raveau Violette, Associate Director, Devices and Digital Therapeutics, AstraZeneca
  • Adam Kalbermatten, Vice President Commercial Development, Becton Dickinson (BD)
  • Bjorg Kaae Hunter, Director, Novo Nordisk
  • Blaine Martin, Director, Customer Success & Training, New Product & Portfolio Expansion, Merck KGaA
  • Blake Green, Director Regulatory Affairs, Amgen Ltd
  • Carsten Worsoe, Principle Scientist Extractables and Leachables, Novo Nordisk
  • Cecile Gross, Global Category Manager - Parenteral, Nemera
  • Cedric Gysel, Health Care Solutions Manager, Johnson & Johnson
  • Cinzia Federico, New Technologies Device Project Leader, Novartis
  • Claus Geiger, Global Device Leader, Sanofi
  • Clemens Gunther, Director, Senior Expert Nonclinical Safety, Bayer AG
  • Danielle Middleton, Associate Medical Director, AstraZeneca
  • Eleanor Kimber, Principal Device Engineer , GlaxoSmithKline
  • Els Ducheyne, Sr Manager Material Compliance & EPR, Johnson & Johnson (Janssen Pharmaceutical)
  • Fatima Bennai-Sanfourche, Senior Director of QA & RA Compliance for Medical Devices and eHealth, Bayer AG
  • Guy Furness, Proprietor and Publisher, ONdrugDelivery
  • Heinrich Martens, Vice President Regulatory Affairs, Fresenius Kabi
  • Joel Richard, Chief Scientific Officer, Medincell
  • Jun Sato, Product Manager, Zeon Europe GmbH
  • Kevin Kusmierek, Senior Scientist Technical Device Leader, CSL Behring GmbH
  • Kim Anker Kristiansen, Principal Scientist, LEO Pharma A/S
  • Klaus Boje, Scientist in Primary Packaging Development, Boehringer Ingelheim
  • Korey Johnson, Managing Partner, Bold Insight US, Bold Insight
  • Marc Moal, Corporate Programme Vice President, Devices & Delivery Solutions, Novo Nordisk
  • Markus Hemminger, Principal Device Engineer, Hoffmann-La Roche
  • Michael Becker, Packaging Engineer, Boehringer Ingelheim Pharma GmbH & Co. KG
  • Mitali Aon, VP and Global Head of Device Development, Sanofi
  • MURRAY SAYCE, Global Head Sustainability Solutions, BSI Group
  • Niels Otterstrom Jensen, Head of TakeBack Program, Novo Nordisk A/S
  • Nima Aghajari, Senior Simulation Engineer, Sanofi
  • Olaf Lebau, Device Manager, Boehringer Ingelheim
  • Paul Draper, Senior Sector Manager - Medical and Scientific, DCA Design International
  • Peter Skutnik, Wearable Injector Platform Leader, BD
  • Petra Renne, Senior Expert Engineering, Packaging Technology, Novartis Pharma AG
  • Salim Bouaidat, Programme Director, Novo Nordisk A/S
  • Sean McPike, Global Product Stewardship Lead, Eli Lilly
  • Sebastian Gerner, President, Alliance to Zero
  • Sebastian Stening, Vice President and Global Head Medical Device Manufacturing Science and Technology, Bayer AG
  • Shannon Clark, CEO, UserWise
  • Steve Hoare, Policy Director, Quality, Regulatory Science & Safety, Association of the British Pharmaceutical Industry
  • Theresa Scheuble,Head Enterprise Design & Innovation, Johnson & Johnson
  • Tim Quigg, Development Director, Crux Product Design
  • Troels Keldmann, DDS Device Consultant and Interim, Keldmann Healthcare A/S

Please fill in your name and email to receive the Conference Agenda of this event.


Copthorne Tara Hotel
Scarsdale Pl, Kensington, W8 5SY
London, UK

Event details
Organizer : SAE Media Group
Event type : Conference
Reference : ASDE-23921